Motohiro Kato1,2, Tomoo Osumi1,2, Shin-Ichi Tsujimoto1,2, Moe Tamura3, Meri Uchiyama2, Kazuhiko Nakabayashi4, Kohji Okamura4, Masanori Yoshida2, Daisuke Tomizawa1, Akihiro Watanabe5, Hiroyuki Takahashi6, Tsukasa Hori7, Shohei Yamamoto8, Kazuko Hamamoto9, Masahiro Migita10, Hiroko Ogata4, Toru Uchiyama11, Hiroe Kizawa12, Hitomi Ueno2, Ryota Shirai2, Masafumi Seki12, Kentaro Ohki2, Junko Takita12, Takeshi Inukai13, Seishi Ogawa14, Toshio Kitamura3, Kimikazu Matsumoto1, Kenichiro Hata4, Susumu Goyama3, Nobutaka Kiyokawa2 (1.Children's Cancer Center, National Center for Child Health and Development, 2.Dept. Pediatric Hemato/Onco Research, National Cent. Child Health and Development, 3.Div. Cellular Therapy, Inst. Medical Science, Univ. Tokyo, 4.Dept. Maternal-Fetal Biology, National Cent. Child Health and Development, 5.Department of Pediatrics, Niigata Cancer Center Hospital, 6.Department of Pediatrics, Toho University, 7.Department of Pediatrics, Sapporo Medical University School of Medicine, 8.Department of Pediatrics, Showa University Fujigaoka Hospital, 9.Dept. Pediatrics, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, 10.Department of Pediatrics, Japanese Red Cross Kumamoto Hospital, 11.Department of Human Genetics, National Cent. Child Health and Development, 12.Dept. Clinical Laboratory Medicine, National Cent. Child Health and Development, 13.Department of Pediatrics, The University of Tokyo, 14.Department of Pediatrics, Yamanashi University, 15.Department of Pathology and Tumor Biology, Kyoto University)
Session information
Oral Session
Oral Session 3-11D AML: Genetic and chromosomal abnormalities
Sun. Oct 14, 2018 3:00 PM - 4:00 PM No.11 (Osaka International Convention Center, 10F 1004-5)
Chair: Yasuhito Nannya (Kyoto University, Department Pathol& tumor Biol, Japan)
Akio Mori1,3, Masahiro Onozawa2,3, Hajime Senjo1,3, Reiki Ogasawara1,3, Minoru Kanaya3, Koh Izumiyama1,3, Makoto Saitoh1,3, Masanori Tanaka1,3, Takeshi Kondo1,3, Takanori Teshima2,3, Masanobu Morioka1,3 (1.Dept. of Hematology, Aiiku Hospital, Sapporo, Japan, 2.Dept. of Hematology, Faculty of Medicine, Hokkaido University, Hokkaido, Japan, 3.North Japan Hematology Study Group; NJHSG)
Tomoo Osumi1,2, Akihiro Watanabe3, Kohji Okamura4, Kazuhiko Nakabayashi4, Masanori Yoshida1,5, Shin-Ichi Tsujimoto1,5, Ryota Shirai1,5, Meri Uchiyama1, Kentaro Ohki1, Hiroyuki Takahashi6, Hiroe Kizawa7, Toru Uchiyama8, Daisuke Tomizawa2, Kenichiro Hata4, Nobutaka Kiyokawa1, Motohiro Kato1,2 (1.Department of Pediatric Hematology and Oncology Research, NCCHD, Tokyo, Japan, 2.Children's Cancer Center, NCCHD, Tokyo, Japan, 3.Department of Pediatrics, Niigata Cancer Center Hospital, Niigata, Japan, 4.Department of Maternal-Fetal Biology, NCCHD, Tokyo, Japan, 5.Department of Pediatrics, Yokohama City University, Yokohama, Japan, 6.Department of Pediatrics, Toho University Omori Medical Center, Tokyo, Japan, 7.Department of Clinical Laboratory Medicine, NCCHD, Tokyo, Japan, 8.Department of Human Genetics, NCCHD, Tokyo, Japan)
Yu Yagi, Takamitsu Matsushima, Makoto Ohyama, Junichi Kiyasu, Yuji Yufu (Iizuka Hospital Hematology)
Yoshimasa Kamoda, Akira Hangaishi, Yusuke Uchibori, Hiroki Hayashida, Hiromitsu Iizuka, Michiko Kida, Kensuke Usuki (Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan)
Honoka Arai1, Motoshi Ichikawa1, Shiho Furuichi1, Fusako Nagasawa1, Wataru Takahashi1, Tomoyuki Handa1, Yuko Nakamura1, Yuka Nakamura1, Ko Sasaki1, Yasuhito Nannya2, Seishi Ogawa2, Kinuko Mitani1 (1.Department of Hematology and Oncology Dokkyo Medical University, 2.Department of Pathology and Tumor Biology, Kyoto University)